Search for: "Grant v. Bristol-Myers Squibb" Results 41 - 60 of 157
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jun 2017, 4:14 am by Edith Roberts
At The Washington Legal Foundation’s Legal Pulse blog, Richard Samp discusses Bristol-Myers Squibb Co. v. [read post]
20 Jun 2017, 4:29 am by Edith Roberts
And in Bristol-Myers Squibb Co. v. [read post]
19 Jun 2017, 1:33 pm by Andrew Hamm
North Carolina. 2:56 p.m.: Ronald Mann analyzed the court’s opinion in Bristol-Myers Squibb Co. v. [read post]
25 Apr 2017, 3:39 am by Edith Roberts
First up is Bristol-Myers Squibb Co. v. [read post]
17 Feb 2017, 12:21 pm by Amy Howe
Bristol-Myers Squibb Co. v. [read post]
27 Jan 2017, 12:52 pm by John Elwood
The court also granted last Thursday in the much less colorful two-time relist Bristol-Myers Squibb Company v. [read post]
20 Jan 2017, 4:26 am by Edith Roberts
In The National Law Journal (subscription or registration required), Tony Mauro reports on one of the grants, Bristol-Myers Squibb Co. v. [read post]
19 Jan 2017, 1:07 pm by Amy Howe
Today’s grant comes in Bristol-Myers Squibb Co. v. [read post]
18 Jan 2017, 10:19 am by John Elwood
(relisted after the January 6 and January 13 conferences)   Bristol-Myers Squibb Co. v. [read post]
12 Jan 2017, 7:01 am by John Elwood
 We expect the Court to issue grants Friday, and those granted cases should make up much of the April argument calendar. [read post]
11 Jan 2017, 7:19 am by Kate Howard
Utah rule, to satisfy the three-year time limitation in Section 13 of the Securities Act with respect to the claims of putative class members (Question granted in Public Employees’ Retirement System of Mississippi v. [read post]
16 Sep 2016, 4:07 am by John Collins
Previously, the Full Court in Bristol-Myers Squibb Company v Apotex Pty Ltd [2015] FCAFC 2 (BMS) upheld Justice Yates’ ruling at first instance that the grant of an ‘exclusive licence’ meant an exclusive licence to undertake all of the activities within the meaning of “exploit” as defined in the Patents Act. [read post]